• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一张用于识别与门诊静脉抗生素治疗(OPAT)服务相关风险的门诊静脉抗生素治疗(OPAT)地图。

An outpatient parenteral antibiotic therapy (OPAT) map to identify risks associated with an OPAT service.

作者信息

Gilchrist Mark, Franklin Bryony Dean, Patel Jignesh P

机构信息

Pharmacy Department, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London W68RF, UK.

出版信息

J Antimicrob Chemother. 2008 Jul;62(1):177-83. doi: 10.1093/jac/dkn152. Epub 2008 Apr 12.

DOI:10.1093/jac/dkn152
PMID:18408239
Abstract

OBJECTIVES

Administering parenteral antibiotics outside the confines of a ward setting is becoming an attractive way of treating infections in the UK. However, as well as having many advantages, an outpatient parenteral antibiotic therapy (OPAT) service potentially introduces new risks to staff and patients involved. In the United States, healthcare organizations are now prospectively analysing processes to try and prevent errors occurring using the Healthcare Failure Mode Effect Analysis (HFMEA) tool. The objectives of this study were to map out and agree the OPAT process and sub-processes and to identify potential OPAT system failures using steps 1-3 of the HFMEA tool, so that the resulting OPAT map can be used to design an OPAT service where risk is minimized.

METHODS

The study was undertaken using a consensus development panel to which the HFMEA process was applied. Key stakeholders in the local OPAT process were invited to join the HFMEA team with the aim of describing and agreeing (defined as 100% participant agreement) an OPAT map, its sub-processes and potential OPAT system failures.

RESULTS

The HFMEA team identified 6 processes, 67 sub-processes and 217 possible failures over the course of four meetings. Key areas identified in the OPAT map concerned identifying and checking patient suitability for an OPAT service, involvement of a multidisciplinary team and robust communication channels.

CONCLUSIONS

An OPAT map was developed, which may serve as a practical model for other organizations setting up a similar service.

摘要

目的

在英国,在病房环境之外给予胃肠外抗生素正成为一种治疗感染的有吸引力的方式。然而,门诊胃肠外抗生素治疗(OPAT)服务除了有许多优点外,也可能给相关工作人员和患者带来新的风险。在美国,医疗保健组织目前正在前瞻性地分析流程,试图使用医疗失效模式与效应分析(HFMEA)工具来防止错误发生。本研究的目的是使用HFMEA工具的第1 - 3步来规划并确定OPAT流程及子流程,并识别潜在的OPAT系统故障,以便最终得到的OPAT流程图可用于设计一个风险最小化的OPAT服务。

方法

本研究采用共识发展小组进行,并应用了HFMEA流程。当地OPAT流程的关键利益相关者被邀请加入HFMEA团队,目的是描述并确定(定义为100%参与者达成一致)一份OPAT流程图、其子流程以及潜在的OPAT系统故障。

结果

HFMEA团队在四次会议过程中识别出6个流程、67个子流程和217个可能的故障。OPAT流程图中确定的关键领域涉及识别和检查患者是否适合OPAT服务、多学科团队的参与以及健全的沟通渠道。

结论

制定了一份OPAT流程图,它可能为其他建立类似服务的组织提供一个实用模型。

相似文献

1
An outpatient parenteral antibiotic therapy (OPAT) map to identify risks associated with an OPAT service.一张用于识别与门诊静脉抗生素治疗(OPAT)服务相关风险的门诊静脉抗生素治疗(OPAT)地图。
J Antimicrob Chemother. 2008 Jul;62(1):177-83. doi: 10.1093/jac/dkn152. Epub 2008 Apr 12.
2
Outpatient parenteral antibiotic therapy for infective endocarditis: a review of 4 years' experience at a UK centre.英国某中心 4 年经验回顾:感染性心内膜炎的门诊患者肠外抗生素治疗。
Postgrad Med J. 2012 Jul;88(1041):377-81. doi: 10.1136/postgradmedj-2011-130355. Epub 2012 Feb 25.
3
Outpatient parenteral antimicrobial therapy and antimicrobial stewardship: challenges and checklists.门诊胃肠外抗菌治疗与抗菌管理:挑战与清单
J Antimicrob Chemother. 2015 Apr;70(4):965-70. doi: 10.1093/jac/dku517. Epub 2014 Dec 23.
4
Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective.门诊静脉用抗生素治疗(OPAT)的临床疗效和成本效益:英国视角。
J Antimicrob Chemother. 2009 Dec;64(6):1316-24. doi: 10.1093/jac/dkp343. Epub 2009 Sep 19.
5
Outpatient parenteral antibiotic therapy (OPAT) in Asia: missing an opportunity.亚洲的门诊胃肠外抗生素治疗(OPAT):错失良机。
J Antimicrob Chemother. 2017 Apr 1;72(4):1221-1226. doi: 10.1093/jac/dkw551.
6
Outpatient parenteral antibiotic therapy (OPAT) in different countries: a comparison.不同国家的门诊胃肠外抗生素治疗(OPAT):一项比较。
Int J Antimicrob Agents. 2004 Nov;24(5):473-8. doi: 10.1016/j.ijantimicag.2004.06.004.
7
Clinical efficacy, cost analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of Sheffield (UK) OPAT service.门诊静脉用抗生素治疗 (OPAT) 的临床疗效、成本分析和患者接受度:谢菲尔德(英国)OPAT 服务十年来的经验。
Int J Antimicrob Agents. 2018 Jan;51(1):26-32. doi: 10.1016/j.ijantimicag.2017.03.016. Epub 2017 Jun 30.
8
Good practice recommendations for paediatric outpatient parenteral antibiotic therapy (p-OPAT) in the UK: a consensus statement.英国儿科门诊患者接受抗生素治疗(p-OPAT)的良好实践推荐:共识声明。
J Antimicrob Chemother. 2015 Feb;70(2):360-73. doi: 10.1093/jac/dku401. Epub 2014 Oct 19.
9
Impact of a multidisciplinary team review of potential outpatient parenteral antimicrobial therapy prior to discharge from an academic medical center.多学科团队对潜在门诊患者出院前接受静脉用抗菌药物治疗的方案评估对出院后抗菌药物使用的影响:来自一家学术医疗中心的回顾性研究
Ann Pharmacother. 2011 Nov;45(11):1329-37. doi: 10.1345/aph.1Q240. Epub 2011 Oct 11.
10
Outpatient parenteral antibiotic therapy: principles and practice.门诊患者的肠外抗生素治疗:原则与实践。
Eur J Intern Med. 2013 Oct;24(7):617-23. doi: 10.1016/j.ejim.2013.03.014. Epub 2013 Apr 18.

引用本文的文献

1
Long-Term Self-Administered Outpatient Parenteral Antimicrobial Therapy in the Treatment of Tuberculosis.长期自我管理的门诊胃肠外抗菌疗法治疗结核病
Drugs. 2025 Jan;85(1):87-96. doi: 10.1007/s40265-024-02122-4. Epub 2024 Dec 29.
2
Making the EHR Work for You-Modifications of an Electronic Health Record System to Improve Tracking and Management of Patients Receiving Outpatient Parenteral Antibiotic Therapy.让电子健康记录系统为您所用——对电子健康记录系统进行修改以改善接受门诊胃肠外抗生素治疗患者的跟踪与管理
Open Forum Infect Dis. 2024 Jan 12;11(2):ofae005. doi: 10.1093/ofid/ofae005. eCollection 2024 Feb.
3
Evaluate the Effectiveness of Outpatient Parenteral Antimicrobial Therapy (OPAT) Program in Saudi Arabia: A Retrospective Study.
评估沙特阿拉伯门诊胃肠外抗菌治疗(OPAT)项目的有效性:一项回顾性研究。
Antibiotics (Basel). 2022 Mar 24;11(4):441. doi: 10.3390/antibiotics11040441.
4
Patient Experiences With Outpatient Parenteral Antibiotic Therapy: Results of a Patient Survey Comparing Skilled Nursing Facilities and Home Infusion.门诊静脉抗生素治疗的患者体验:一项比较专业护理机构和家庭输液的患者调查结果
Open Forum Infect Dis. 2019 Nov 4;6(12):ofz471. doi: 10.1093/ofid/ofz471. eCollection 2019 Dec.
5
Outpatient parenteral antimicrobial therapy and antibiotic stewardship: opponents or teammates?门诊患者的肠外抗菌治疗与抗菌药物管理:是对手还是队友?
Infection. 2019 Apr;47(2):169-181. doi: 10.1007/s15010-018-1250-1. Epub 2018 Nov 15.
6
Sociodemographic and clinical factors associated with acceptance of outpatient parenteral antibiotic therapy in a Singapore tertiary hospital from 2014 to 2017.2014 年至 2017 年期间,新加坡一家三级医院中与接受门诊肠外抗生素治疗相关的社会人口学和临床因素。
Eur J Clin Microbiol Infect Dis. 2019 Feb;38(2):277-284. doi: 10.1007/s10096-018-3424-2. Epub 2018 Nov 14.
7
Managing an outpatient parenteral antibiotic therapy team: challenges and solutions.管理门诊肠外抗生素治疗团队:挑战与解决方案。
Ther Clin Risk Manag. 2014 Jun 18;10:459-65. doi: 10.2147/TCRM.S48906. eCollection 2014.
8
Outpatient parenteral antimicrobial therapy for surgery patients: A comparison with previous standard of care.手术患者的门诊肠外抗菌治疗:与既往标准治疗的比较。
Can J Infect Dis Med Microbiol. 2013 Summer;24(2):74-8. doi: 10.1155/2013/754897.
9
Outpatient parenteral antimicrobial therapy.门诊胃肠外抗菌治疗
Can J Infect Dis Med Microbiol. 2013 Spring;24(1):9-11. doi: 10.1155/2013/205910.
10
Outpatient parenteral antimicrobial therapy (OPAT) and the general physician.门诊胃肠外抗菌治疗与普通内科医生
Clin Med (Lond). 2013 Oct;13(5):495-9. doi: 10.7861/clinmedicine.13-5-495.